Mercedes-Benz has filed a patent for an amphibious SUV concept that could transform the G-Class into a true water-going vehicle. No boat hull, no propeller: instead, inflatable wheel-arch inserts, software-controlled per-wheel torque, and adaptive suspension dipping. The filing, published as DE102024002781B3, lists
EPO
What is the difference between a German, European, and PCT patent?
A German patent protects an invention only in Germany; a European patent, following examination by the EPO, protects it in many European countries; and a PCT application is an international application procedure that consolidates time frames and country options but is not itself a patent.
G 1/25 as a milestone for the EPO
With the G 1/25 case before the Enlarged Board of Appeal, the European patent system faces a landmark decision: Must the description be amended to align with amended claims in order to ensure legal certainty, or is a clear formulation of the claims sufficient? The answer will have immediate implications for applicants,
PCT pilot program between the European Patent Office and IP Australia
The new PCT pilot program between the European Patent Office (EPO) and IP Australia will offer Australian applicants a faster and more cost-effective route to high-quality patent protection in Europe from March 1, 2026. In this article, you will learn how the program works, what specific advantages it offers, and what
Changes to EPO fees
The EPA fees will be adjusted on April 1, 2026, with selective structural changes and a significantly increased reduction for supplementary European searches under certain ISAs/SISAs.
PAP is in force: UPC possible in 2022
It has been expected for years, and now the Unified Patent Court (UPC) is probably coming in 2022: The last phase of the construction of the UPC, the so-called PAP, came into force on 19 January 2022. So to say, the UPC is "born", now it has to become grown up.
PCT application – does the principle of joint applicants apply?
In general, the principle "joint applicants approach" to European patent applications. But does this also apply to an international PCT application? The EPO has recently decided to refer this question to the Enlarged Board of Appeal.
EPO: Priority documents via DAS – almost from everywhere
The EPO has ended the automatic exchange of priority documents between the EPO and the USPTO, KIPO and CNIPA. From 1 January 2022, priority documents from the USPTO, KIPO and CNIPA will only be accepted via the Digital Access Service (DAS).
Vindication of national parts of a European patent
The right from a European patent with an Employee’s invention is regulated under § 60 EPC. Also, this applies as a standard for the vindication on a European bundle patent, is ruled by the German OLG Frankfurt, i.e. for claiming the transfer of illegally filed European patent rights. And: an upper signature instead of
Enlarged Board of Appeal: Prohibition of double patenting
The Enlarged Board of Appeal has ruled on important issues of double patenting claiming priority: The prohibition of double patenting also applies to parent and divisional applications as well as applications claiming the same priority - in same destination states.
Biopatent on malting barley: appeal dismissed
The European Patent Office (EPO) has rejected an appeal against a patent on malting barley by the beer companies Heineken and Carlsberg. The core issue is that a bio-patent is allowed on mutations, but not on classical breeding.
EPO practice of national patent offices – more uniform
Minimum grounds for oppositions against patents and formalities for designating the inventor: these two areas in the EPO practice of national patent offices are now uniform for EPO member states, the EPO reports.
No European patent on genetically modified apes
Two European patents with claims on genetically modified apes were severely restricted by the EPO yesterday, and the claims on genetically modified animals are to be deleted. A decision that sends a signal on laboratory animals in research.
EU Biopatent: Enlarged Board of Appeal annuls fundamental decisions
The Enlarged Board of Appeal of the EPO has published an important new opinion on patentability as a biopatent: it revokes its fundamental decisions G 2/12 and G 2/13 and resolves the conflict between Rule 28 and Art. 53 EPC.
Distinctiveness of 3D marks / shape marks with additional elements
The European Trademark Offices have agreed on a common decision-making practice in trademark law for the assessment of the distinctiveness of 3D marks / shape marks with additional elements. This has been in force since 1 April 2020 and leads to a further harmonisation of trademark law in the EU.














